Bridging the gap: Geometry-centric discriminative manifold distribution alignment for enhanced classification in colorectal cancer imaging

Abstract

The early detection of colorectal cancer (CRC) through medical image analysis is a pivotal concern in healthcare, with the potential to significantly reduce mortality rates. Current Domain Adaptation (DA) methods strive to mitigate the discrepancies between different imaging modalities that are critical in identifying CRC, yet they often fall short in addressing the complexity of cancer's presentation within these images. These conventional techniques typically overlook the intricate geometrical structures and the local variations within the data, leading to suboptimal diagnostic performance. This study introduces an innovative application of the Discriminative Manifold Distribution Alignment (DMDA) method, which is specifically engineered to enhance the medical image diagnosis of colorectal cancer. DMDA transcends traditional DA approaches by focusing on both local and global distribution alignments and by intricately learning the intrinsic geometrical characteristics present in manifold space. This is achieved without depending on the potentially misleading pseudo-labels, a common pitfall in existing methodologies. Our implementation of DMDA on three distinct datasets, involving several unique DA tasks, has consistently demonstrated superior classification accuracy and computational efficiency. The method adeptly captures the complex morphological and textural nuances of CRC lesions, leading to a significant leap in domain adaptation technology. DMDA's ability to reconcile global and local distributional disparities, coupled with its manifold-based geometrical structure learning, signals a paradigm shift in medical imaging analysis. The results obtained are not only promising in terms of advancing domain adaptation theory but also in their practical implications, offering the prospect of substantially improved diagnostic accuracy and faster clinical workflows. This heralds a transformative approach in personalized oncology care, aligning with the pressing need for early and accurate CRC detection.